Dr. Andreas Pilz

Clinical strategy and clinical development Analysis and interpretation of clinical study results Presentation of clinical studies at international conferences Planing, preparation and execution of scientific advisory board meetings Write study protocols, IB and review key study document Write clinical sections of regulatory document

Scientific strategy and product development Analytical method development and validation Identification of business development opportunities within pharma and Biotech industry Portfolio strategy and management Assessment of scientific grants and collaboration opportunities Interimsmanagement EHS

Development of bacterial anti-P. acnes vaccines Management of multiple national and international R&D projects with CROs, academic and private partners Responsibility for R&D budget and milestone progress Development of various assays and models (in house and external) Supervision of scientific personnel

Leader of an immunology team for preclinical/clinical assay development and validation for viral and bacterial vaccines GLP study leader, clinical trial testing and regulatory filings Assay transfer internally and to CROs Trained Six Sigma specialist with experience in CAPA and root cause analyis Qualification and validation of analytical methods and equipment

Function of Type I Interferons in elderly mice Development of mouse models and ex vivo analyzes of immune cells from adult and elderly mice Studies of in vitro and in vivo adjuvant effects on innate and adaptive immunity

Regulation of adaptive Immunity by Type I Interferons Development of cell activation, cell death and proliferation assays Experience with adoptive transfer mouse models for cellular immunity Development of spontaneous and induced tumor models in mice Training of master students

Microbiology, Immunology, Signaltransduction